CCL2 increased the expression level of the CCR1 ligand CCL3 in MAMs via CCR2, and the signaling generated by the CCL3/CCR1 interaction enhanced and stabilized the cancer cell-MAM interaction in part through integrin α4 binding to VCAM1 expressed on tumor cells in an autocrine manner. This evidence concerns the gene CCL3 and cancer.